Last mentioned: Mar 22, 2026
Enphase Energy (ENPH) Deadline
Final day for investors to move for lead plaintiff status in the ENPH securities class action.
Enphase Energy Deadline
Critical cutoff for ENPH investors to seek lead plaintiff appointment.
ENPH Deadline
Final day for Enphase Energy investors to move for lead plaintiff status.
Lead Plaintiff Deadline
Final date for investors to petition the court to lead the Enphase class action.
Picard Medical (PMI) Deadline
Final day for investors to move for lead plaintiff status in the PMI securities class action.
Picard Medical Deadline
Deadline for PMI shareholders to join the securities class action.
PMI Deadline
Final day for Picard Medical investors to move for lead plaintiff status.
Paysafe (PSFE) Deadline
Final day for investors to move for lead plaintiff status in the PSFE securities class action.
Paysafe Deadline
Final day for PSFE investors to move for lead plaintiff status.
PSFE Deadline
Final day for Paysafe investors to move for lead plaintiff status.
Enphase Suit Filed
Pomerantz LLP files class action litigation against Enphase Energy in federal court.
Litigation Expansion
Pomerantz confirms additional filings and alerts for Enphase and Nektar Therapeutics.
Enphase Energy Filing
Pomerantz LLP files a separate class action against Enphase Energy alleging securities fraud.
Secondary Nektar Notice
A follow-up announcement clarifies the class period and lead plaintiff deadline for Nektar investors.
Litigation Launch
Pomerantz LLP officially announces class action litigation against Nektar Therapeutics.
Litigation Filed
Pomerantz LLP announces the filing of a class action lawsuit against Nektar.
Nektar Litigation Announced
Pomerantz LLP announces the first class action filing against Nektar Therapeutics.
Insider Sale
Director Thurman Rodgers sells 137,250 shares of Enphase stock.
Nektar Financial Update
Nektar files updated results of operations and financial condition reports.
Initial Filing
Pomerantz LLP commences class action proceedings against Enphase Energy.
Pomerantz LLP has initiated class action litigation against Nektar Therapeutics and Enphase Energy, alleging securities fraud and misleading statements. These filings highlight a growing trend of legal scrutiny in the biotech and renewable energy sectors as companies navigate volatile market conditions and regulatory shifts.
Pomerantz LLP has filed a class action lawsuit against solar technology leader Enphase Energy, alleging securities law violations following a period of significant stock volatility. The litigation marks a critical regulatory challenge for the renewable energy sector as it navigates a broader market downturn.
Pomerantz LLP has initiated class action litigation against Nektar Therapeutics, alleging the company made false or misleading statements regarding its clinical programs and business prospects. The lawsuit seeks to recover damages for investors following significant stock volatility linked to the company's oncology pipeline performance.
Pomerantz LLP has initiated class action lawsuits against Nektar Therapeutics and Enphase Energy, alleging violations of federal securities laws. The litigation follows a series of financial disclosures and regulatory filings in early 2026 that triggered significant market volatility for both companies.
Goldman Sachs has released its definitive list of top 10 solar and green energy stock picks for 2026, signaling a bullish outlook for the sector. The list highlights high-conviction companies positioned to benefit from long-term decarbonization trends and a shift toward fundamental value in renewable energy.
Faruqi & Faruqi, LLP has issued critical reminders for investors in Paysafe, Picard Medical, and Enphase Energy regarding upcoming lead plaintiff deadlines in April 2026. These legal actions follow periods of financial reporting and market volatility, signaling a tightening of regulatory and investor oversight for these entities.
Enphase Energy, Paysafe, and Picard Medical are facing critical deadlines in April 2026 for securities class action lawsuits led by Faruqi & Faruqi, LLP. The legal pressure on Enphase highlights broader volatility and disclosure risks within the renewable energy sector.
Faruqi & Faruqi, LLP has issued critical lead plaintiff deadlines for securities class actions against Paysafe, Picard Medical, and Enphase Energy. Investors in these high-growth sectors have until April 2026 to join litigation alleging potential federal securities law violations.
The 20th EnergySage Marketplace Report reveals a historic shift in the residential energy sector as consumers rushed to secure incentives before their expiration. This pull-forward in demand has significantly altered market dynamics, with storage attachment rates reaching new highs and solar pricing showing unexpected resilience.
Market analysts are highlighting green energy and cannabis as key sectors for 2026, driven by regulatory shifts and maturing business models. As interest rates stabilize, these policy-sensitive industries are attracting renewed investor interest as they transition from speculative plays to fundamental value.
As the renewable energy sector navigates a complex landscape of fluctuating interest rates and evolving federal policy, specific stocks in solar, wind, and storage are emerging as key indicators of market health. This briefing examines the performance and outlook for top-tier green energy players amid a broader shift toward grid modernization.